Find in Library

<p>Abstract</p> <p>Introduction</p> <p>To the best of our knowledge, this is the first time triptorelin has been reported to cause benign intracranial hypertension.</p> <p>Case presentation</p> <p>A 43-year-old Caucasian woman who suffered from chronic menorrhagia was started on triptorelin, a gonadotrophin-releasing hormone analogue. Three days later, she developed gradually worsening headaches accompanied by bilateral visual disturbance. Examination revealed bilateral papilledema and enlarged blind spots on her visual fields. A diagnosis of benign intracranial hypertension was made and confirmed on magnetic resonance imaging.</p> <p>Conclusion</p> <p>We recommend that patients at high risk (women who are overweight and of reproductive age) who are using any gonadotrophin-releasing hormone analogue (for example, triptorelin) should be periodically monitored for the possible development of benign intracranial hypertension.</p>